000 | 01940cgm a2200397 a 4500 | ||
---|---|---|---|
001 | HST4030 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 160115s2015 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a4030 _bHenry Stewart Talks |
035 | _a(UkLoHST)3187 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aZhang, Rumin, _u(Merck, USA) _4spk |
|
245 | 1 | 0 |
_aQuantitative analysis of receptor allosterism and its implication for drug discovery _h[electronic resource] / _cRumin Zhang. |
260 |
_aLondon : _bHenry Stewart Talks, _c2015. |
||
300 |
_a1 online resource (1 streaming video file (57 min.) : _bcolor, sound). |
||
490 | 1 |
_aThe biomedical & life sciences collection, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: G protein-coupled receptors (GPCRs) -- Receptor agonism and allosterism -- Orthosteric and allosteric binders -- Inverse, partial and full agonists -- Positive, silent and negative allosteric modulators (PAMs, SAMs and NAMs) -- Allosteric two-state model and general operational model with constitutive receptor activity -- Optimal design of experiment -- Global curve fitting analysis of affinity and efficacy parameters -- Beta supremacy -- Monte Carlo simulations. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aCell receptors. | |
650 | 0 | _aDrug development. | |
650 | 0 | _aDrug receptors. | |
650 | 0 | _aPharmaceutical chemistry. | |
650 | 2 | _aDrug Agonism. | |
650 | 2 | _aDrug Discovery. | |
650 | 2 | _aReceptors, Cytoplasmic and Nuclear. | |
650 | 2 |
_aReceptors, G-Protein-Coupled _xagonists. |
|
650 | 2 |
_aReceptors, G-Protein-Coupled _xchemistry. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/3187/ |
999 |
_c76781 _d76781 |